<DOC>
	<DOCNO>NCT03055559</DOCNO>
	<brief_summary>The haemoglobin level patient iron deficiency increase clinical relevant 12 week treatment GlobiFer Forte .</brief_summary>
	<brief_title>Trial Protocol GlobiFer - Oral Iron Repletion</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<criteria>1 . ≥ 18 ≤ 60 year age 2 . Signed write informed consent 3 . Hb ≥ 8 ≤ 10g/dl 4 . Female 1 . History acquire iron overload , know haemochromatosis first relatives haemochromatosis , allergic disorder ( asthma , eczema , anaphylactic reaction ) . 2 . Known hypersensitivity oral iron preparation . 3 . Diseases , iron supplementation allow contraindicate . 4 . Patients current oral intravenous iron supplementation 5 . History erythropoietin therapy previous 30 day schedule erythropoietin therapy blood transfusion duration study . 6 . Patients iron supplementation within last 30 day . 7 . Other reason investigator 's judgment argue inclusion patient trial . 8 . Inability comprehend study protocol 9 . Participation another clinical trial ( currently within last 30 day )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Iron , Hemoglobin , Feritin , erytrocyty . transferin</keyword>
</DOC>